Funding partnerships Strong donor-driven funding model with annual revenue between ten and twenty five million and a history of multi-million allocations to research and patient services. Potential sales opportunity in collaborations with corporate partners, foundations, and impact investors to expand fundraising platforms and sponsor programs.

Research collaboration Active emphasis on innovative blood cancer research with significant grants and co-funding initiatives, including recent partnerships with patient groups. Opportunity to offer research support services, grant management platforms, and data collaboration tools to streamline funding and outcomes tracking.

Digital engagement Tech stack includes Drupal, Mautic, AWS, and analytics tools, indicating mature digital operations and targeted outreach capabilities. Opportunity to provide advanced marketing automation, donor analytics, and secure digital experiences to boost fundraising efficiency.

Advocacy and patient support Strategic focus on patient resources, education, and advocacy across Canada with nationwide service delivery and no government funding. Potential to offer patient portals, multilingual information systems, and advocacy platforms to scale impact and engagement with stakeholders.

Strategic collaboration Recent cross-organizational collaboration with Myeloma Canada signals openness to joint ventures and co-funded initiatives. Potential for partnership programs, joint grant solicitations, and shared awareness campaigns to expand reach and diversify funding sources.